SNAP Message Board - Msg: 13023054

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNAP

SNAP 7.800

+2.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (88)	3/2/2000 10:16:00 AM
From: Mike McFarland	Read Replies (1) of 124

Synaptic Pharmaceutical Alpha-Adrenergic Program Update biz.yahoo.com Merck & Co., Inc. has relinquished its license to Synaptic's alpha-adrenergic technology and related patents, thereby paving the way for Synaptic to make all of its technology and patents available for licensing to others who have been working in this field.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next